In a follow-up vote, the panel voted that the benefits of a third dose for older adults and individuals at high risk of severe COVID-19 outweigh the risks.
In a follow-up vote, the panel voted that the benefits of a third dose for older adults and individuals at high risk of severe COVID-19 outweigh the risks.